Jane Street Group, LLC Ligand Pharmaceuticals Inc Put Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$127.69 - $165.85 $306,456 - $398,040	-2,400 Reduced 52.17%	2,200 $340,000
Q3 2021 Nov 16, 2021	BUY	$102.33 - $144.73 $61,398 - $86,838	600 Added 15.0%	4,600 $641,000
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $32.9 Million - $45.4 Million	-291,500 Reduced 98.65%	4,000 $525,000
Q1 2021 May 18, 2021	BUY	$99.52 - $215.83 $27.1 Million - $58.8 Million	272,600 Added 1190.39%	295,500 $45 Million
Q4 2020 Feb 17, 2021	SELL	$80.55 - $106.05 $2.02 Million - $2.66 Million	-25,100 Reduced 52.29%	22,900 $2.28 Million
Q3 2020 Nov 17, 2020	SELL	$89.56 - $126.72 $5.5 Million - $7.78 Million	-61,400 Reduced 56.12%	48,000 $4.58 Million
Q2 2020 Aug 17, 2020	BUY	$68.28 - $123.65 $6.71 Million - $12.2 Million	98,300 Added 885.59%	109,400 $12.2 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $272,491 - $463,884	4,300 Added 63.24%	11,100 $807,000
Q4 2018 Feb 15, 2019	BUY	$128.36 - $272.13 $872,848 - $1.85 Million	6,800 New	6,800 $923,000

256

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.